XBI (SPDR S&P Biotech ETF): Congressional Trading Activity
Who traded XBI?
XBI (SPDR S&P Biotech ETF) appears in 11 STOCK Act disclosures from 3 filers (9 purchases, 2 sales), most recently Thomas H Tuberville on May 8, 2024.
- Thomas H Tuberville — 4 trades, last on May 8, 2024
- David P. Joyce — 3 trades, last on Jun 30, 2023
- John F Reed — 4 trades, last on Mar 9, 2018
Disclosed trades
| Filer | Trade date | Type | Amount |
|---|---|---|---|
| Thomas H Tuberville | May 8, 2024 | Purchase | $1,001 - $15,000 |
| Thomas H Tuberville | May 8, 2024 | Purchase | $1,001 - $15,000 |
| Thomas H Tuberville | May 8, 2024 | Purchase | $1,001 - $15,000 |
| Thomas H Tuberville | May 8, 2024 | Purchase | $1,001 - $15,000 |
| David P. Joyce | Jun 30, 2023 | Sale (Full) | $15,001 - $50,000 |
| John F Reed | Mar 9, 2018 | Sale (Partial) | $1,001 - $15,000 |
| John F Reed | Jun 19, 2017 | Purchase | $1,001 - $15,000 |
| John F Reed | Mar 6, 2017 | Purchase | $1,001 - $15,000 |
| John F Reed | Mar 6, 2017 | Purchase | $1,001 - $15,000 |
| David P. Joyce | Feb 23, 2017 | Purchase | $1,001 - $15,000 |
| David P. Joyce | Feb 17, 2017 | Purchase | $1,001 - $15,000 |